Redhill Biopharma Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Redhill Biopharma Ltd - ADR
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
/ 
Others were interested in
Frequently asked questions
To buy Redhill Biopharma Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Redhill Biopharma Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Redhill Biopharma Ltd - ADR is RDHL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Redhill Biopharma Ltd - ADR has its primary listing on NASDAQ (Small cap). You can trade Redhill Biopharma Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Redhill Biopharma Ltd - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Redhill Biopharma Ltd - ADR as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like Redhill Biopharma Ltd - ADR or others.